Clinical Immunology Communications (Dec 2023)

Cross-protective immunity induced by omicron variant of SARS-CoV-2

  • Selia Chowdhury,
  • Md. Shahraj Chowdhury,
  • Nurjahan Shipa Chowdhury,
  • Samia Chowdhury,
  • Shajeda Chowdhury

Journal volume & issue
Vol. 4
pp. 41 – 44

Abstract

Read online

The newly discovered SARS-CoV-2 Omicron (B.1.1.529) variant is the most antigenically unique SARS-CoV-2 variant of concern to date, which is presently prevalent across most of the world. According to a number of studies, the Omicron variant causes a restricted immune response after infection. A critical component of study is determining the efficacy of Omicron-induced immunity and if it is cross-protective against other variants.

Keywords